UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Annals of oncology, 2014-02, Vol.25 (2), p.339-345

2014

Volltextzugriff (PDF)

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Annals of oncology, 2015-02, Vol.26 (2), p.313-320

2015

Volltextzugriff (PDF)

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Annals of oncology, 2015-08, Vol.26 (8), p.1685-1691

2015

Volltextzugriff (PDF)

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial

British journal of surgery, 2021-04, Vol.108 (3), p.308-314

2021

Volltextzugriff (PDF)

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

British journal of cancer, 2013-08, Vol.109 (3), p.589-596

2013

Volltextzugriff (PDF)

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

Annals of oncology, 2014-02, Vol.25 (2), p.366-371

2014

Volltextzugriff (PDF)

P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Breast (Edinburgh), 2023-04, Vol.68, p.S123-S124

2023

Volltextzugriff (PDF)

Efficacy of tamoxifen + aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

British journal of cancer, 2013-04, Vol.108 (7), p.1408-1414

2013

Volltextzugriff (PDF)

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

The Lancet (British edition), 2015-10, Vol.386 (10001), p.1341-1352

Anon

2015

Volltextzugriff (PDF)

Intercalibration of hydroacoustic and mark-recapture methods for assessing the spawning population size of a threatened fish species

Journal of fish biology, 2009-10, Vol.75 (6), p.1356-1370

2009

Volltextzugriff (PDF)

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

The Lancet (British edition), 2015-10, Vol.386 (10001), p.1353-1361

2015

Volltextzugriff (PDF)

Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial

Journal of clinical oncology, 2023-11, Vol.41 (33), p.5118-5130

2023

Volltextzugriff (PDF)

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial

British journal of surgery, 2021-09, Vol.108 (9), p.e317-e318

2021

Volltextzugriff (PDF)

Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast

Journal of the National Cancer Institute. Monographs, 2010, Vol.41, p.162-177

2010

Volltextzugriff (PDF)

LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer

Annals of oncology, 2020-09, Vol.31, p.S1145-S1145

2020

Volltextzugriff (PDF)

Biodiversity and resource use of larval chironomids in relation to environmental factors in a large river

Freshwater biology, 2002-06, Vol.47 (6), p.1065-1087

FESL, CHRISTIAN

2002

Volltextzugriff (PDF)

Abstract P1-17-05: The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-17-05

2019

Volltextzugriff (PDF)

Niche-Oriented Species-Abundance Models: Different Approaches of Their Application to Larval Chironomid (Diptera) Assemblages in a Large River

The Journal of animal ecology, 2002-11, Vol.71 (6), p.1085-1094

Fesl, Christian

2002

Volltextzugriff (PDF)

Adjuvant denosumab in early breast cancer: Disease-free survival analysis of 3,425 postmenopausal patients in the ABCSG-18 trial

JOURNAL OF CLINICAL ONCOLOGY, 2018, Vol.36 (15_suppl), p.500-500

2018

Volltextzugriff (PDF)

Abstract OT3-05-08: PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT3-05-08-OT3-05-08

2018

Volltextzugriff (PDF)

Dragonfly associations (Insecta: Odonata) in relation to habitat variables: a multivariate approach

Hydrobiologia, 2003-05, Vol.497 (1-3), p.169-180

2003

Volltextzugriff (PDF)

Use of invertebrate traits for the biomonitoring of European large rivers: the effects of sampling effort on genus richness and functional diversity

Freshwater biology, 2005-01, Vol.50 (1), p.159-173

2005

Volltextzugriff (PDF)

PALLAS: PALbociclib CoLlaborative adjuvant study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer

Annals of oncology, 2017-09, Vol.28, p.v66-v66

2017

Volltextzugriff (PDF)

Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.GS6-04-GS6-04

2018

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Humans
(31)
Female
(27)
Biological And Medical Sciences
(17)
Adult
(15)
Middle Aged
(15)
Breast Neoplasms - Drug Therapy
(14)
Oncology
(13)
Breast Cancer
(11)
Medicin Och Hälsovetenskap
(11)
Aged
(10)
Chemotherapy, Adjuvant
(10)
Fundamental And Applied Biological Sciences. Psychology
(10)
Animal, Plant And Microbial Ecology
(9)
Antineoplastic Agents, Hormonal - Therapeutic Use
(9)
Breast Neoplasms - Pathology
(9)
Cancer Therapies
(9)
Clinical Neurology
(9)
Male
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Efficacy of tamoxifen + aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

Intercalibration of hydroacoustic and mark-recapture methods for assessing the spawning population size of a threatened fish species

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial

Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast

LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer

Biodiversity and resource use of larval chironomids in relation to environmental factors in a large river

Abstract P1-17-05: The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer

Niche-Oriented Species-Abundance Models: Different Approaches of Their Application to Larval Chironomid (Diptera) Assemblages in a Large River

Adjuvant denosumab in early breast cancer: Disease-free survival analysis of 3,425 postmenopausal patients in the ABCSG-18 trial

Abstract OT3-05-08: PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer

Dragonfly associations (Insecta: Odonata) in relation to habitat variables: a multivariate approach

Use of invertebrate traits for the biomonitoring of European large rivers: the effects of sampling effort on genus richness and functional diversity

PALLAS: PALbociclib CoLlaborative adjuvant study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer

Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34

Suchergebnisse filtern